Global generic drug and specialty pharmaceuticals maker Mylan has turned to Skadden, Arps, Slate, Meagher & Flom, Magic Circle shop Slaughter and May, and Indian firm Platinum Partners for counsel on its $1.6 billion acquisition of Indian generic injectable drug manufacturer Agila Specialties from parent Strides Arcolab. Haynes and Boone, Herbert Smith Freehills, and firms from Brazil and India are advising the seller.
Seven Firms Advise on Mylan's $1.6 Billion Generic Drug Buy
The Am Law Daily
February 28, 2013
This content is now available at LexisNexis®.
The ALM® and LexisNexis® Content Alliance
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM’s legal news publications. LexisNexis® customers will be able to access and use ALM’s content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM’s other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM’s content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
If you are not currently a LexisNexis subscriber, contact 1-800-227-4908 to find out more or click here to have a customer representative contact you directly.